Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin J Churchyard

Showing results (61-70 of 135) with videos related to

Pageof 14
Sort By:
The Journal of Infectious Diseases|November 8, 2017
Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We're There?Sara C Auld, Anne G Kasmar, David W Dowdy, et al.
Plos One|August 21, 2012
Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence surveySusan E Dorman, Violet N Chihota, James J Lewis, et al.
BMC Infectious Diseases|July 18, 2008
Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: a cohort studyKatherine L Fielding, Salome Charalambous, Amy L Stenson, et al.
American Journal of Respiratory and Critical Care Medicine|March 5, 2002
Polymorphisms in the tumor necrosis factor-alpha gene promoter may predispose to severe silicosis in black South African minersElizabeth L Corbett, Nadine Mozzato-Chamay, Anthony E Butterworth, et al.
American Journal of Respiratory and Critical Care Medicine|September 12, 2009
HIV infection does not affect active case finding of tuberculosis in South African gold minersJames J Lewis, Salome Charalambous, John H Day, et al.
Plos One|November 19, 2013
Eligibility for isoniazid preventive therapy in South African gold minesJames J Lewis, Katherine L Fielding, Alison D Grant, et al.
Plos One|October 25, 2011
Cytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV-infected gold miners in South AfricaKatherine Fielding, Ai Koba, Alison D Grant, et al.
Trials|April 16, 2015
Evaluation of a point-of-care tuberculosis test-and-treat algorithm on early mortality in people with HIV accessing antiretroviral therapy (TB Fast Track study): study protocol for a cluster randomised controlled trialKatherine L Fielding, Salome Charalambous, Christopher J Hoffmann, et al.
AIDS Patient Care and Stds|January 11, 2011
Contrasting reasons for discontinuation of antiretroviral therapy in workplace and public-sector HIV programs in South AfricaMaysoon Dahab, Karina Kielmann, Salome Charalambous, et al.
Thorax|November 25, 2010
Twelve-monthly versus six-monthly radiological screening for active case-finding of tuberculosis: a randomised controlled trialGavin J Churchyard, Katherine Fielding, Surita Roux, et al.
Pageof 14

Showing results (61-70 of 135) with videos related to

Sort By:
Pageof 14
The Journal of Infectious Diseases|November 8, 2017
Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We're There?Sara C Auld, Anne G Kasmar, David W Dowdy, et al.
Plos One|August 21, 2012
Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence surveySusan E Dorman, Violet N Chihota, James J Lewis, et al.
BMC Infectious Diseases|July 18, 2008
Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: a cohort studyKatherine L Fielding, Salome Charalambous, Amy L Stenson, et al.
American Journal of Respiratory and Critical Care Medicine|March 5, 2002
Polymorphisms in the tumor necrosis factor-alpha gene promoter may predispose to severe silicosis in black South African minersElizabeth L Corbett, Nadine Mozzato-Chamay, Anthony E Butterworth, et al.
American Journal of Respiratory and Critical Care Medicine|September 12, 2009
HIV infection does not affect active case finding of tuberculosis in South African gold minersJames J Lewis, Salome Charalambous, John H Day, et al.
Plos One|November 19, 2013
Eligibility for isoniazid preventive therapy in South African gold minesJames J Lewis, Katherine L Fielding, Alison D Grant, et al.
Plos One|October 25, 2011
Cytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV-infected gold miners in South AfricaKatherine Fielding, Ai Koba, Alison D Grant, et al.
Trials|April 16, 2015
Evaluation of a point-of-care tuberculosis test-and-treat algorithm on early mortality in people with HIV accessing antiretroviral therapy (TB Fast Track study): study protocol for a cluster randomised controlled trialKatherine L Fielding, Salome Charalambous, Christopher J Hoffmann, et al.
AIDS Patient Care and Stds|January 11, 2011
Contrasting reasons for discontinuation of antiretroviral therapy in workplace and public-sector HIV programs in South AfricaMaysoon Dahab, Karina Kielmann, Salome Charalambous, et al.
Thorax|November 25, 2010
Twelve-monthly versus six-monthly radiological screening for active case-finding of tuberculosis: a randomised controlled trialGavin J Churchyard, Katherine Fielding, Surita Roux, et al.
Pageof 14